Anti-ADDL antibodies and uses thereof

Details for Australian Patent Application No. 2012232964 (hide)

Owner Merck Sharp & Dohme Corp. Northwestern University

Inventors Bett, Andrew J.; Dodson, Elizabeth Chen; Kinney, Gene; Viola, Kirsten L.; Chang, Lei; Lambert, Mary P.; An, Zhiqiang; Shughrue, Paul; Breese, Robert; Klein, William; Strohl, William R.; Liang, Xiaoping; Acton, Paul

Agent FB Rice

Pub. Number AU-A-2012232964

Parent 2005306997

Filing date 28 September 2012

Wipo publication date 18 October 2012

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

18 October 2012 Application Open to Public Inspection

  Published as AU-A-2012232964

18 October 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012232965-Dispensing Valve

2012232963-Debarking chain with passing links